252 related articles for article (PubMed ID: 9838900)
1. [Antiangiogenic therapy].
Toi M
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2003-9. PubMed ID: 9838900
[TBL] [Abstract][Full Text] [Related]
2. Cancer experts offer healthy dose of skepticism toward hype over antiangiogenesis agents.
Phillips P
JAMA; 1998 Jun; 279(24):1936-7. PubMed ID: 9643843
[No Abstract] [Full Text] [Related]
3. Anticancer drug targets: approaching angiogenesis.
Keshet E; Ben-Sasson SA
J Clin Invest; 1999 Dec; 104(11):1497-501. PubMed ID: 10587512
[No Abstract] [Full Text] [Related]
4. Angiogenesis and antiangiogenic therapy.
Sledge GW; Miller KD
Curr Probl Cancer; 2002; 26(1):1-60. PubMed ID: 11961506
[No Abstract] [Full Text] [Related]
5. Cancer 'cure' article stirs up hot debate.
Wadman M
Nature; 1998 May; 393(6681):104-5. PubMed ID: 9603508
[No Abstract] [Full Text] [Related]
6. [Research on the endothelium and new therapeutic strategies in tumors and cardiovascular diseases].
Dejana E
Recenti Prog Med; 1999 Feb; 90(2):64-8. PubMed ID: 10208094
[No Abstract] [Full Text] [Related]
7. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
[TBL] [Abstract][Full Text] [Related]
8. [Vascular growth and non-small cell lung cancer].
Fan X; Guo X; Han B
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):499-502. PubMed ID: 11718044
[No Abstract] [Full Text] [Related]
9. [Tumor angiogenesis].
Ono M; Kuwano M
Seikagaku; 1998 Sep; 70(9):1159-70. PubMed ID: 9796411
[No Abstract] [Full Text] [Related]
10. [Therapeutic prospects of angiogenesis inhibitors in cancerology].
Bout JC; Soncin F; Vandenbunder B
Rev Mal Respir; 1999 Nov; 16(5):854-5. PubMed ID: 10612161
[No Abstract] [Full Text] [Related]
11. Angiogenesis: the unifying concept in cancer?
Saphir A
J Natl Cancer Inst; 1997 Nov; 89(22):1658-9. PubMed ID: 9390530
[No Abstract] [Full Text] [Related]
12. Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment.
Hayes AJ; Li LY; Lippman ME
BMJ; 1999 Mar; 318(7187):853-6. PubMed ID: 10092266
[No Abstract] [Full Text] [Related]
13. [The clinical perspective of angiogenesis inhibitors].
Radema SA; Witteveen PO; Gebbink MB; Voest EE
Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1675-80. PubMed ID: 14513538
[TBL] [Abstract][Full Text] [Related]
14. Angiostatin suppresses malignant glioma growth in vivo.
Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
[TBL] [Abstract][Full Text] [Related]
15. [Tumor dormancy therapy for hepatocellular carcinoma].
Hori T; Ido A; Tsubouchi H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():824-8. PubMed ID: 11762064
[No Abstract] [Full Text] [Related]
16. Are angiostatin and endostatin cures for cancer?
Harris AL
Lancet; 1998 May; 351(9116):1598-9. PubMed ID: 9620709
[No Abstract] [Full Text] [Related]
17. Angiogenesis and cancer: recent advances.
Cáceres W; González S
P R Health Sci J; 2003 Jun; 22(2):149-51. PubMed ID: 12866139
[TBL] [Abstract][Full Text] [Related]
18. [Opening to the age of regenerative medicine--the mechanism of angiogenesis].
Murota S
Kokubyo Gakkai Zasshi; 2002 Jun; 69(2):81-8. PubMed ID: 12136664
[No Abstract] [Full Text] [Related]
19. Angiogenesis and tumor metastasis.
Zetter BR
Annu Rev Med; 1998; 49():407-24. PubMed ID: 9509272
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E
In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
